Concepedia

Christina Taubert

CT

Statistics

Publications

5

Citations

292

H-Index

5

Active since

2014

Affiliations

Evercyte (Austria)(Current)

Christina Taubert is an author at Evercyte (Austria) specializing in immunology, life sciences, and immune checkpoint inhibitors.

ORCID

Publications per year

2014–2021

5

Publications

5

Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results

Wenya Linda Bi, Lakshmi Nayak, David M. Meredith et al. · Neuro-Oncology · 2021 · 92 citations · Full text

, , +17

Enhanced activation of an amino-terminally truncated isoform of the voltage-gated proton channel HVCN1 enriched in malignant B cells

Elayne Hondares, Mark Brown, Boris Musset et al. · Proceedings of the National Academy of Sciences · 2014 · 91 citations · Full text

, , +17

Differential Production of Type I IFN Determines the Reciprocal Levels of IL-10 and Proinflammatory Cytokines Produced by C57BL/6 and BALB/c Macrophages

Ashleigh Howes, Christina Taubert, Simon Blankley et al. · The Journal of Immunology · 2016 · 43 citations · Full text

, , +17

Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL

Christian Schmidl, Gregory I. Vladimer, André F. Rendeiro et al. · Nature Chemical Biology · 2019 · 42 citations · Full text

, , +12

A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway

Melanie Wurm, Otmar Schaaf, Katharina Reutner et al. · Molecular Cancer Therapeutics · 2021 · 24 citations · Full text

, , +17

1–5 of 5